Connect with us

News

Can femtech bridge the gap and meet the needs of dual diagnosis care?

Published

on

Femtech is helping women better understand their bodies and make positive changes to improve their health. In this article, we will explore how Femtech is bridging the gap between physical and mental health and supporting dual diagnosis care.

What is Dual Diagnosis Care?

Dual diagnosis care is a specific treatment that helps individuals who are struggling with both a mental health condition and a substance abuse disorder. Dual diagnosis care can support conditions and disorders such as:

Co-occurring Disorders

This is where a person’s mental health condition and drug or alcohol problem occur together.

Mental Health Conditions

Mental health is a very real threat to wellbeing and quality of life. Conditions like schizophrenia, anxiety, and depression can greatly impact a person’s life.

Substance Misuse

This disorder encompasses individuals who have issues with drugs, alcohol, or both.

The interplay between mental illness and substance abuse can be complicated. Oftentimes, both are closely entwined; one condition might have led to the other or might make the other condition worse. As such, you can’t deal with one without having to deal with the other.

How Does a Diagnosis Become a Dual Diagnosis?

According to Giles Fourie, Director and Co-owner of White River Manor, “Many people diagnosed with a substance use disorder (SUD) are also suffering from a co-existing mental health or behavioural disorder.

This is known as a dual diagnosis. It is also commonly referred to as comorbidity, or co-occurring mental health and substance use disorder.”

There are many ways one issue can worsen into multiple, particularly when it comes to the intricate balance between mental health and wellbeing and physical health.

Here are a few of the most common ways that a single diagnosis can become a dual diagnosis:

How One Diagnosis Can Become Two
Self-medication

When a person is diagnosed with a mental health condition, for example, they are sometimes prescribed medication to help manage their symptoms.

Unfortunately, out of desperation, some people may abuse these prescriptions or turn to stronger forms of substance abuse in an attempt to alleviate their symptoms.

This can lead to regular substance abuse, worsening mental health, and sometimes the onset of a mental disorder.

Substance Use

Misuse of substances can trigger mental health conditions or exacerbate mental health struggles that were already present. And long-term substance abuse can cause a person to develop a mental disorder.

Shared Risk Factors
Family Genetics

Some people come from families prone to mental health conditions or substance abuse disorders. This means some people are more genetically predisposed to facing mental health or substance abuse challenges than others.

The Brain’s Influence

The brain can have a strong influence on a person’s predisposition to substance abuse. For those with a pre-existing mental health condition, substance abuse can potentially feel more rewarding and enjoyable, dramatically increasing the likelihood of increased use in the future.

Environmental Factors

For individuals who experienced excessive stress, trauma, or abuse in early childhood, there is often an increased risk of developing a substance abuse disorder or a mental health condition.

Individual Factors

Everyone is different and influenced or affected by different things. There can be many reasons why a person develops a mental health condition or turn to substance abuse. Some of the most common reasons include:

Low Self-Esteem

People with low self-esteem are more likely to turn to drugs or alcohol as a way to feel better about themselves and increase their confidence. Prolonged substance abuse can result in a reliance on substances to feel ‘normal’.

Lack of Medical Treatment or Professional Support

Unfortunately, many people (women in particular) lack the correct treatment and support needed to manage their health conditions helpfully. When medical conditions are left undiagnosed or untreated, this can lead to frustration and upset, sometimes resulting in substance abuse or mental health struggles.

Prenatal Exposure

Foetuses exposed to drugs, alcohol, or other toxins in the womb are more likely to partake in substance abuse and/or develop a mental health condition during their lifetime.

As you can see, dual diagnosis disorders are complex and often result in a number of factors intertwining, from genetic predispositions and environmental influences to psychological factors and lack of support.

It can be hard to identify which condition came first in many cases. As such, both must be dealt with and treated simultaneously.

How Femtech is Meeting the Needs of Dual Diagnosis Care

Femtech stands for “Female Technology” and refers to the use of technology, such as apps, to address women’s physical and mental health needs. Femtech has a wide reach and touches on most areas of female health and wellbeing, from menstrual cycles, fertility, pregnancy, and menopause to digital therapeutics and counselling.

It’s a beautiful thing; empowering women to take control of their health. And Femtech is taking things even further by offering advanced tools that helpfully integrate mental health support with personalised tools to manage and track physical symptoms.

Let’s take a closer look.

Mental Health Integration and Care

More often than not, health struggles can affect mental wellbeing and vice versa. Understanding this intricate balance is important. Femtech for mental health integrates mental health care and wellbeing into health apps to provide:

Emotional Support

Having the opportunity to write out your symptoms, journal your thoughts, take part in guided medications, and gain access to mental health resources is invaluable. It’s helping countless women manage their mental health alongside their physical health.

Combined Tracking

Femtech is offering combined tracking capabilities where apps can track an individual’s mental wellbeing alongside their physical symptoms, showing how one can impact the other. This provides a well-rounded picture of health so that women can take proactive steps towards positive change.

Personalised Health Support

Once women have tracked how their mental health is affected by their physical health, and vice versa, they will have an accurate record that can be shared with a doctor or healthcare provider. This can provide health professionals with invaluable insights into a woman’s health, often supporting the treatment and future management of dual diagnosis disorders.

Improving Treatment for Dual Diagnosis Patients

Dual diagnosis can be a tricky area of medicine and one that is hard to treat without lots of knowledge about and understanding of the patient. Femtech is revolutionising dual diagnosis treatment through the provision of:

Personalised Treatment Plans

Dual diagnosis looks different for everyone. That’s why it’s so important to have a detailed and personalised treatment plan. Femtech can be utilised to provide valuable insights into a patient’s health journey, from both physical and mental perspectives, providing a well-rounded view into the patient’s world and supporting appropriate treatment plans.

Staying on Track

Once the treatment plan has been created, Femtech can support patients in staying on track with their treatments by providing medication reminders, tracking health progress, and offering resources for further support.

Improved Care Coordination

Organising care for a person with a dual diagnosis disorder can be challenging. Femtech supports this process by providing a more concise view into patient health and wellbeing so that patient communications can be clearly made and treatments can be appropriately suggested.

Can Femtech Bridge the Dual Diagnosis Care Gap?

Absolutely. Femtech is already revolutionising the world of medicine as we know it. Femtech allows women to take their health into their own hands, claim responsibility and control over their bodies, and have data-driven evidence that backs up their health concerns.

We are excited to see where Femtech goes and how it will continue to transform dual diagnosis care for so many.

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Entrepreneur

WHIS 2026 adds 18 new speakers to October summit agenda

Published

on

The Women’s Health Innovation Summit (WHIS), the event uniting the global  women’s health ecosystem, has just announced 18 new speakers joining the agenda for  its 2026 summit, taking place October 13–15 at Encore Boston Harbor.

The latest additions bring further depth across pharma, clinical research, health  systems, venture, and policy, reinforcing WHIS’s role as the only platform where the full women’s health ecosystem convenes under one roof.

Newly confirmed speakers include:

  • Kelle Moley, MD – VP, Women’s Health Early Phase Clinical Development, Cardiometabolic Research, Eli Lilly & Company
  • Justine Levin-Allerhand – Executive Partner, Chief Corporate Development Officer & COO, Flagship Labs, Flagship Pioneering
  • Sebnem Yildirimoglu, MD, PMP – Executive Director, Women’s Health Strategy, Premier Research
  • Terri Stewart – Head of Global Healthcare & Government Affairs, EMD Serono
  • Dr. Morag Grassie – Executive Director, Blavatnik Fund for Innovation, Yale
  • Sandra Butler – Director, Design Impact, Mass General Brigham
  • Zhenya Lindgardt – Chief Executive Officer, Sera Prognostics
  • Sadie Morahan – Head of US Revenue, Withings Health Solutions
  • Angela Drew, PhD – Vice President, Regulatory Strategy, Premier Research
  • Dr. Stephanie Lahr – CMIO, Aqurio
  • Michelle Andrews – Contributing Writer, KFF Health News
  • Charlotte Williams – CEO, My Bump Hub
  • Clint Dart, MS – Director, NIH Women’s Health Data Coordinating Center, Premier Research
  • Cass Sanford – US Venture Advisor, FemTech Lab
  • Megan Mukuria – Founder & CEO, ZanaAfrica
  • Tiffany Inglis, MD, FACOG – Chief Medical Officer, Sera Prognostics
  • Angelean Hendrix, PhD – Vice President, Pharmacometrics and MIDD, Premier Research
  • Amanda Ducach – CEO & Co-founder, EmaEQ

“WHIS is where the women’s health industry comes together to take action,” said Poppy Howard-Wall, Event Director at WHIS.

“This latest wave of speakers reflects exactly the kind of cross-sector expertise our attendees expect – from global pharma and clinical research leadership to venture, health systems, and grassroots innovation.

“It’s this breadth that makes WHIS the room where things actually move forward.”

Bringing the Full Ecosystem Together

These additions join a growing 2026 agenda spanning four content tracks that reflect the  full lifecycle of healthcare innovation, from early-stage research and development  through to patient delivery, system transformation, and commercial scale.

Attendees can expect over 1,000 senior decision-makers, 120+ expert speakers, four dedicated stages, and more than 10 hours of curated 1:1 meetings.

Full speaker and agenda details are available at whisusa.com/speakers-2026.

About WHIS

The Women’s Health Innovation Summit is the only platform uniting the full women’s  health ecosystem – providers, payers, employers, pharma leaders, investors, and innovators -to increase deal flow, expand reimbursement, improve access, and deliver better outcomes for women at every stage of life.

 

Continue Reading

Diagnosis

Millions in England to be offered ‘gamechanging’ home testing kits for cervical cancer

Published

on

Millions of women who have missed cervical screening in England will be offered free NHS home HPV tests.

The initiative is aimed at women who are not up to date with screening, with NHS estimates suggesting as many as 4 million have fallen behind.

The home kits contain a swab for collecting a vaginal sample, which is returned to the NHS free of charge and tested in a laboratory for high-risk human papillomavirus (HPV).

If high-risk HPV is detected through a home test, patients will be asked to attend a cervical screening appointment with a clinician.

HPV is a group of viruses that can be passed on through sexual contact and cause no symptoms. About 13 high-risk types are known to cause 99.7 per cent of cervical cancers.

Starting on Tuesday, eligible women aged between 30 and 65 who have not attended screening appointments will receive invitations through the NHS app, text message, email or letter.

They will then be able to order a testing kit through the NHS app or website.

The scheme is part of the NHS’s target to eliminate cervical cancer by 2040.

Dr Sue Mann, national clinical director for women’s health at NHS England, said: “Screening saves thousands of lives each year by preventing cancers and catching them earlier, but only around two-thirds of women are attending cervical screening appointments when invited by the NHS.

“Offering millions of women an alternative test they can do from the comfort of their own homes will be a gamechanger – making it easier than ever for them to get tested for HPV.”

Women aged between 24 and 64 are invited for cervical screening every five years, or more often if HPV is detected.

NHS England figures show 68.8 per cent of eligible women are up to date with cervical screening, below the 80 per cent target.

Mann said: “There are lots of reasons that may stop women from getting their cervical screening – embarrassment, lack of time, or worries about discomfort – and these kits provide a discreet and convenient option we hope will encourage more women to take up the life-saving test.

“So, if you’re invited to take part, please order a test – it’s a simple swab you can do at home in minutes.”

Athena Lamnisos, chief executive of the Eve Appeal, welcomed the move, saying that self-testing at home would be a “step-change” for many women.

Michelle Mitchell, chief executive of Cancer Research UK, said: “Cervical screening is a powerful tool that saves lives – it can prevent cervical cancer or spot it at an earlier stage when treatment is more likely to be successful.

“While it’s best for cervical screening to be done by a nurse or doctor, there are barriers that make it challenging for some people to attend. At-home HPV self-testing kits will help more people take part in a way that works for them.”

Health secretary Yvette Cooper said the aim was to make it as easy and convenient as possible for women to keep up with their screening.

She said: “This is the future NHS we are building – there for all of us when we need it, and acting as early as possible to stop preventable deaths.”

Continue Reading

Menopause

Quarter of women miss work due to menstual symptoms, survey finds

Published

on

Nearly a quarter of women often miss work because of menstrual symptoms, according to a survey examining hormonal health among women in full-time work in Ireland.

The survey looked at the impact of menstruation, fertility and motherhood, and perimenopause and menopause.

Research from The Menopause Hub found more than one in three women who had not disclosed a menstrual health issue at work said the lack of a clear workplace policy was the reason.

More than a quarter said they did not think their concerns would be taken seriously, while 22 per cent cited embarrassment and 18 per cent feared being judged.

Nearly half of respondents said better workplace support would have made them feel less stressed, while 40 per cent said it would have made them feel more valued. Some 36 per cent said they would have felt more comfortable speaking up.

Some 76 per cent of women surveyed said they experienced menstrual health issues, with 23 per cent of those often missing work because of symptoms.

Nearly half of respondents, 49 per cent, said they felt uncomfortable talking about menstruation at work.

One respondent said: “As a woman, we try to get through the day, sometimes in pain that can’t be seen. We feel emotionally and physically drained.”

The research also found that 62 per cent of those who experienced baby loss reported a moderate or significant impact on work attendance.

More than half of respondents who experienced depression during pregnancy also reported a moderate or significant impact on attendance.

Some 63 per cent of mothers said it was “difficult” to return to work after pregnancy, while nearly half said their maternity pay arrangement had negatively affected their financial wellbeing.

One respondent said: “I almost walked away. The only reason I stayed was because I had to provide for my family.”

The survey also found that nearly half of respondents said menopause had some impact on their attendance, while more than six in 10 reported an impact on their work performance.

Some 44 per cent of women said they were “uncomfortable” discussing perimenopause and menopause at work.

One person said they were “already terrified of losing my job at my age:

“I need to just struggle through this without support or acknowledgement. That’s basically workplace discrimination.”

The Menopause Hub chief executive Loretta Dignam said women’s hormonal health has been treated as a “private or personal issue” for too long, “when the reality is that it has a very real impact on women’s working lives”.

“The fundamental point is that women are not ‘mini men.’

“Our biology is different, and workplaces that were largely designed around a male model of health and working life need to evolve to recognise that.

“What is striking is how many women continue to show up, perform, push through and progress at work while managing significant physical and emotional symptoms, often without the policies, understanding or practical support they need,” Dignam said.

She added that because expectations are changing, Gen Z and Gen Alpha employees will be “far less willing than previous generations to accept workplaces that ignore their health and wellbeing”.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.